返回 Agenda
SESSION 2: TRIAL OBJECTIVES
Session Chair(s)
Kerry Gordon
Senior Director, Biostatistics, Japan, China, Europe and North America
IQVIA, United Kingdom
James Matcham
Head, Early Clinical Development Biometrics
AstraZeneca, United Kingdom
The objective of this session is to detail different types of primary objectives for trials and review how the results of these trials are assessed.
- Superiority Trials
- Non-Inferiority trials
- Equivalence trials
- Observational trials
- Confidence intervals
- Interpretation of results
Speaker(s)
TRIAL OBJECTIVES
James Matcham
AstraZeneca, United Kingdom
Head, Early Clinical Development Biometrics